ultomiris
alexion europe sas - ravulizumab - hemoglobinuria, paroxysmal - szelektív immunszuppresszánsok - paroxysmal nocturnal haemoglobinuria (pnh)ultomiris is indicated in the treatment of adult and paediatric patients with a body weight of 10 kg or above with pnh:- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months (see section 5. atypical haemolytic uremic syndrome (ahus)ultomiris is indicated in the treatment of patients with a body weight of 10 kg or above with ahus who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab (see section 5. generalized myasthenia gravis (gmg)ultomiris is indicated as an add-on to standard therapy for the treatment of adult patients with gmg who are anti-acetylcholine receptor (achr) antibody-positive. neuromyelitis optica spectrum disorder (nmosd)ultomiris is indicated in the treatment of adult patients with nmosd who are anti-aquaporin 4 (aqp4) antibody-positive (see section 5. ultomiris is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh):- in patients with haemolysis with clinical symptom(s) indicative of high disease activity. - in patients who are clinically stable after having been treated with eculizumab for at least the past 6 months. ultomiris is indicated in the treatment of adult patients with atypical haemolytic uremic syndrome (ahus) who are complement inhibitor treatment-naïve or have received eculizumab for at least 3 months and have evidence of response to eculizumab.
roxid 300 mg filmtabletta
t3a pharma group gmbh - általános -
mencevax ac (meningococcus poliszacharid vakcina)
glaxosmithkline kft. - vakcina (bakteriális) -
menpovac a+c (meningococcus vakcina a+c szerocsoport)
chiron behring gmbh&co kg - vakcina (bakteriális) -
mencevax acw135y (meningococcus poliszacharid vakcina)
glaxosmithkline kft. - vakcina (bakteriális) -
meningitec konjugált meningococcus c vakcina
wyeth kft. - vakcina (bakteriális) -
menjugate konjugált meningococcus c-crm197 vakcina
chiron s.r.l. - vakcina (bakteriális) -
rotateq
merck sharp & dohme b.v. - rotavírus g1 szerotípus, g2 szerotípus, g3 szerotípus, g4 szerotípus, p1 szerotípus - immunization; rotavirus infections - vaccines, viral vaccines - a rotateq 6 hetes és 32 hetes kor közötti csecsemők aktív immunizálására javallt a rotavírusfertőzés által okozott gastroenteritis megelőzésére. a rotateq kell használni alapján hivatalos ajánlások.
rotarix
glaxosmithkline biologicals s.a. - humán rotavírus, élő attenuált - immunization; rotavirus infections - a vakcinák - a rotarix 6-24 hetes csecsemők aktív immunizálására javallt a rotavírus fertőzés miatti gastroenteritis megelőzésére. a használata a rotarix-et alapuló hivatalos ajánlás.
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimetil-fumarát - a sclerosis multiplex, a relapszáló-remittáló - immunszuppresszánsok - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.